Anacor Pharmaceuticals Company Profile (NASDAQ:ANAC)

Analyst Ratings

Consensus Ratings for Anacor Pharmaceuticals (NASDAQ:ANAC) (?)
Ratings Breakdown: 2 Hold Rating(s), 3 Buy Rating(s)
Consensus Rating:Buy (Score: 2.60)
Consensus Price Target: $119.13 (20.09% upside)

Analysts' Ratings History for Anacor Pharmaceuticals (NASDAQ:ANAC)
Show:
DateFirmActionRatingPrice TargetActions
5/18/2016MizuhoDowngradeBuy -> Neutral$98.00 -> $99.25View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/16/2016Jefferies GroupReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/16/2016WedbushDowngradeOutperform -> Neutral$148.00 -> $99.25View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/10/2016Cowen and CompanyReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/9/2015JMP SecuritiesInitiated CoverageOutperform$173.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/21/2015Bank of America Corp.UpgradeNeutral -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/21/2015Goldman Sachs Group Inc.UpgradeNeutral -> Buy$195.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/9/2014Avondale PartnersInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/24/2014 forward)

Earnings

Earnings History for Anacor Pharmaceuticals (NASDAQ:ANAC)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/4/2016        
5/10/2016Q116($0.35)($0.36)$19.53 million$17.54 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/29/2016Q415($0.30)($0.43)$27.93 million$21.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/3/2015Q315($0.23)($0.37)$25.60 million$24.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2015Q215($0.32)($0.30)$18.55 million$21.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/6/2015Q115($0.49)($0.30)$9.20 million$15.26 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/12/2015Q414($0.61)($0.24)$4.74 million$9.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/6/2014Q314($0.66)($0.74)$3.67 million$3.96 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2014Q214($0.63)($0.58)$3.03 million$2.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2014Q114($0.39)($0.51)$2.82 million$4.15 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/13/2014Q413($0.39)$3.01$2.85 million$8.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/7/2013Q313($0.39)($0.41)$2.57 million$3.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/8/2013Q2 2013($0.39)($0.36)$2.60 million$3.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/9/2013Q1 2013($0.39)($0.42)$2.57 million$1.71 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/14/2013Q4 2012($0.45)($0.36)$3.25 million$3.28 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/7/2012Q312($0.45)($0.46)$3.18 million$2.47 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/9/2012($0.45)($0.47)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/10/2012($0.44)($0.48)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/13/2012($0.35)($0.52)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/10/2011($0.41)($0.16)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/11/2011($0.45)($0.54)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/5/2011($0.31)($0.49)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Anacor Pharmaceuticals (NASDAQ:ANAC)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.45)($0.30)($0.38)
Q2 20162($0.41)($0.36)($0.39)
Q3 20162($0.44)($0.33)($0.39)
Q4 20162($0.74)($0.53)($0.64)
Q1 20171($0.53)($0.53)($0.53)
Q2 20171$0.52$0.52$0.52
Q3 20171$1.32$1.32$1.32
Q4 20171$1.67$1.67$1.67
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Anacor Pharmaceuticals (NASDAQ:ANAC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Anacor Pharmaceuticals (NASDAQ:ANAC)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/1/2016Graeme BellCFOSell751$99.28$74,559.28View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/23/2016Keith R LeonardDirectorSell9,000$99.70$897,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/16/2016Anders D HoveDirectorSell353,881$99.59$35,243,008.79View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/29/2016Ryan T SullivanEVPSell3,125$66.33$207,281.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/8/2016Anders D HoveDirectorSell229,301$71.10$16,303,301.10View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/22/2016Paul L BernsCEOSell37,500$60.31$2,261,625.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/19/2016Vincent P. IppolitoEVPSell20,000$95.41$1,908,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/15/2016Lee ZaneSVPSell1,466$89.57$131,309.62View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/4/2016Paul L. BernsCEOSell2,533$112.35$284,582.55View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/4/2016Ryan T. SullivanVPSell733$111.78$81,934.74View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/4/2016Vincent P. IppolitoEVPSell855$112.28$95,999.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/11/2015Paul L. BernsCEOSell20,000$117.26$2,345,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/10/2015Ryan T. SullivanVPSell10,000$110.41$1,104,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/15/2015Lee ZaneSVPSell14,000$139.84$1,957,760.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/15/2015Paul L. BernsCEOSell20,000$139.83$2,796,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/13/2015Paul L BernsCEOSell20,000$138.69$2,773,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/15/2015Lee ZaneSVPSell12,000$69.05$828,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/15/2015Jacob J PlattnerVPSell8,920$63.73$568,471.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/14/2015Carmen R RodriguezVPSell61,942$62.73$3,885,621.66View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/29/2015Ryan T SullivanVPSell3,125$53.61$167,531.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/27/2015Paul L BernsCEOSell50,000$63.64$3,182,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/15/2015Jacob J PlattnerVPSell8,920$62.81$560,265.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/23/2015Geoffrey M ParkerCFOBuy3,000$52.43$157,290.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/16/2015Jacob J PlattnerVPSell8,920$55.60$495,952.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/16/2015Lee ZaneSVPSell12,000$56.44$677,280.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/4/2015Sanjay ChandaSVPSell5,000$45.00$225,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/3/2015Vincent P IppolitoEVPSell9,000$43.88$394,920.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/2/2015Jacob J PlattnerVPSell6,875$44.02$302,637.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/2/2015Kirk R MaplesSVPSell600$43.95$26,370.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/2/2015Jacob J PlattnerVPSell6,875$32.09$220,618.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/26/2014Paul L BernsCEOSell25,000$30.82$770,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/12/2014Lucy ShapiroDirectorSell289,685$35.11$10,170,840.35View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/11/2014Lee ZaneSVPSell4,900$36.09$176,841.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/9/2014Kirk R MaplesSVPSell60,000$36.52$2,191,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/1/2014Jacob J PlattnerVPSell6,875$33.34$229,212.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/1/2014Kirk R MaplesSVPSell600$33.38$20,028.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/26/2014Sanjay ChandaSVPSell5,000$35.00$175,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2014Jacob J PlattnerVPSell6,875$29.32$201,575.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/1/2014Jacob J PlattnerVPSell6,875$24.47$168,231.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/26/2014Anders D HoveDirectorSell20,000$25.00$500,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/19/2014Anders D HoveDirectorSell740,000$24.87$18,403,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/16/2014Anders D HoveDirectorSell90,000$24.99$2,249,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/10/2014Sanjay ChandaSVPSell10,000$24.25$242,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/8/2014Geoffrey M ParkerCFOBuy6,590$21.82$143,793.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/27/2014Mark LeschlyDirectorSell13,067$22.50$294,007.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/20/2014Kirk MaplesSVPSell1,500$14.15$21,225.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/21/2014Kirk MaplesSVPSell1,500$15.60$23,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/24/2014Geoffrey ParkerCFOBuy5,000$20.11$100,550.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/21/2014Lucy ShapiroDirectorSell80,000$21.14$1,691,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/20/2014Kirk MaplesSVPSell3,000$22.39$67,170.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/18/2014Geoffrey ParkerCFOBuy2,410$22.60$54,466.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/5/2014David PerryCEOSell65,000$20.22$1,314,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/20/2014Kirk MaplesSVPSell3,000$19.33$57,990.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/5/2014David PerryCEOSell15,000$17.00$255,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/21/2014Kirk MaplesSVPSell3,000$20.27$60,810.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/9/2014David PerryCEOSell65,000$16.32$1,060,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/9/2013David PerryCEOSell40,328$16.23$654,523.44View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/26/2013Geoffrey ParkerCFOBuy10,000$13.40$134,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/25/2013Geoffrey ParkerCFOBuy10,000$12.85$128,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/14/2013Kirk MaplesSVPSell1,052$9.71$10,214.92View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/13/2013Geoffrey ParkerCFOBuy50,000$8.34$417,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/19/2013Geoffrey M ParkerCFOBuy23,046$5.20$119,839.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/18/2013Geoffrey M ParkerCFOBuy20,000$5.22$104,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/14/2013Kirk R MaplesSVPSell5,600$5.39$30,184.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/26/2012Kirk R MaplesSVPSell3,000$5.22$15,660.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/1/2012Kirk R MaplesSVPSell3,000$5.81$17,430.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/5/2012Lucy ShapiroDirectorSell30,000$6.67$200,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/22/2012Geoffrey M ParkerCFOBuy5,000$6.19$30,950.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Anacor Pharmaceuticals (NASDAQ:ANAC)
DateHeadline
07/22/16 02:29 PMStock to Watch: Price Target and Company Rating Review for Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) - TGP
07/21/16 08:04 PMHow Many Anacor Pharmaceuticals Inc (NASDAQ:ANAC)'s Analysts Are Bearish? - Press Telegraph
07/20/16 10:36 AMNow Available: Anacor Pharmaceuticals, Inc. (ANAC) - Financial and Strategic SWOT Analysis Review
07/19/16 02:29 PMAnacor Pharmaceuticals, Inc. (NASDAQ:ANAC) Earnings Concentration and Analyst Target Watch - Engelwood Daily
07/19/16 02:29 PMEquity Roundup: Stock Performance Focus on Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) - Press Telegraph
07/16/16 02:27 PMAnacor Pharmaceuticals Incorporated (NASDAQ:ANAC) Shorted Shares Increased 16.25% After Market Selling - Consumer Eagle
07/15/16 06:45 PMConsensus Target and Stock Rating Report: Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) - Telanagana Press
07/15/16 06:45 PMCrowd Rating and Earnings Recap for Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) - Telanagana Press
07/14/16 11:23 AMAnacor Pharmaceuticals, Inc. (NASDAQ:ANAC) Wall Street Analyst Recommendation Outlook - Telanagana Press
07/13/16 10:35 AMPfizer Inc.: Pfizer Announces the Publication of Final Results from Two ...
07/12/16 06:59 AMTrading Performance and Target Watch for Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) - Press Telegraph
07/08/16 02:29 PMAnacor Pharmaceuticals, Inc. (NASDAQ:ANAC): Tracking Consensus Projections and Analyst Ratings - Telanagana Press
07/08/16 10:33 AMHypertension Pipeline Review, H1 2016 - 100 Companies & Drug Profiles - Research and Markets
07/07/16 02:30 PMAnacor Pharmaceuticals, Inc. (NASDAQ:ANAC) Stock Update: Check on Ratings and Target Price - Telanagana Press
07/06/16 08:14 PMOne of the Best Biotech Stocks to Buy Now Could Soar 115%
07/06/16 08:14 PMAnacor Pharmaceuticals, Inc. Pipeline Market Review, Growth, Analysis, Size and Forecast 2016 – 2020
07/06/16 07:06 PMWhat Can We Expect from the Pfizer-Anacor Deal? -
07/06/16 07:06 PMThe Pfizer-Anacor Deal Wrapped Up in June: Now What? -
07/06/16 02:30 PMAnacor Pharmaceuticals, Inc. (ANAC) Current Analyst Ratings - Fiscal Standard
07/06/16 07:17 AMCan Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) Improve on the Earnings Front? - Engelwood Daily
07/05/16 07:16 AMAnacor Pharmaceuticals, Inc. Pipeline Market Review, Growth, Analysis, Size and Forecast 2016 – 2020 - Medgadget.com (blog)
07/04/16 07:18 AMBroker Outlook For The Week Ahead Anacor Pharmaceuticals, Inc. (ANAC) - Fiscal Standard
07/02/16 02:32 PMKingdon Capital Management LLC Increased Anacor Pharmaceuticals INC (NASDAQ:ANAC) by $41.16 Million as ... - Press Telegraph
07/01/16 02:30 PMMerger & Acquisition Activity in the Biotech Sector Potentially on the Rise after Pfizer's $5.2 Billion Purchase
06/30/16 02:35 PMBill Gates Calls U.S. Drug Pricing System ‘Better Than Most’
06/30/16 10:22 AMAnacor Pharmaceuticals, Inc. (NASDAQ:ANAC) Company Rating and Target Watch - Telanagana Press
06/29/16 02:30 PMWere Analysts Bearish Anacor Pharmaceuticals Inc (NASDAQ:ANAC) This Week? - Engelwood Daily
06/28/16 07:43 AMTop Stock Pick for Quarter: Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) - Engelwood Daily
06/27/16 02:49 PMAnacor Pharmaceuticals, Inc. (NASDAQ:ANAC) Earnings Glance and Target Price Review - Engelwood Daily
06/27/16 02:49 PMPfizer Inc. (NYSE:PFE) completed its acquisition of Anacor Pharmaceuticals, Inc - Inside Trade
06/27/16 07:15 AMAnacor Pharmaceuticals, Inc. (ANAC) Broker Price Targets For The Coming Week - Fiscal Standard
06/24/16 07:42 PMStock Tracing Lower on the Week Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) - Engelwood Daily
06/24/16 02:30 PMAnacor Pharmaceuticals Inc.: Pfizer Completes Acquisition Of Anacor - The Wall Street Transcript
06/24/16 12:21 PMPfizer Completes Anacor Acquisition -
06/24/16 12:10 PMPfizer Completes Acquisition Of Anacor - [at noodls] - cec9f68a-d756-4fdd-a308-1a94408c647a.pdf June 24, 2016 Tender offer for all of the outstanding shares of Anacor common stock expired as scheduled immediately after 11:59 p.m., New York City time, on June ...
06/24/16 08:56 AMNew Broker Ratings For Anacor Pharmaceuticals, Inc. (ANAC) - FTSE News
06/24/16 08:56 AMHC Stocks News Ring: Anacor Pharmaceuticals Inc (NASDAQ:ANAC), Opko Health Inc. (NYSE:OPK) - share market updates (press release)
06/24/16 08:22 AMANACOR PHARMACEUTICALS, INC. Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Triggering Event -
06/23/16 07:37 PMWhy Pfizer (PFE) is a Great Stock to Buy for the Long Run -
06/22/16 02:30 PMAnacor Pharmaceuticals (NASDAQ:ANAC) Analyst Rating Consensus - Trade Calls
06/21/16 07:16 AMHC Stocks Updates: Anacor Pharmaceuticals Inc (NASDAQ:ANAC), Mylan NV (NASDAQ:MYL) - share market updates (press release)
06/20/16 02:29 PMReview of Analysts Ranking: ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) , Anacor Pharmaceuticals, Inc. (NASDAQ ... - Street Updates
06/20/16 08:59 AMDermatological Drugs Market To See 4.29% CAGR Driven By Pharmaceutical Industry To 2018 : Radiant Insights,Inc
06/19/16 07:14 AMAnacor Pharmaceuticals, Inc. (ANAC) Analyst Price Targets For The Coming Week - Fiscal Standard
06/19/16 07:14 AMAnacor Pharmaceuticals, Inc. Pipeline Review, Industry Analysis, Market Size and Forecast 2016 – 2020 - Medgadget.com (blog)
06/17/16 10:25 AMGlobal Tuberculosis Pipeline 2016 Market Report on 64 Companies
06/17/16 10:25 AMNoteworthy Thursday Option Activity: ANAC, CACC, BMRN
06/15/16 02:33 PMPerformance to see: Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) - News Oracle
06/14/16 02:28 PMPrice Target Highlight: Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) - News Oracle
06/14/16 02:28 PMEarnings Expectations of the Stocks: Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC), Juniper Networks, Inc. (NYSE ... - Beacon Chronicle

Social

About Anacor Pharmaceuticals

Anacor Pharmaceuticals logoAnacor Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on discovering, developing and commercializing small-molecule therapeutics derived from its boron chemistry platform. Its lead product development candidate is crisaborole topical ointment, approximately 2%, a non-steroidal topical anti-inflammatory phosphodiesterase-4 (PDE-4) inhibitor in development for the treatment of mild-to-moderate atopic dermatitis and psoriasis. Its product, KERYDIN (tavaborole) topical solution, approximately 5%, is an oxaborole antifungal approved by the United States Food and Drug Administration (FDA) for the topical treatment of onychomycosis of the toenails. It also has a pipeline of other internally discovered topical and systemic boron-based compounds in early-stages of research and development, which include AN3365. Its compound, AN5568 (SCYX-7158), is licensed to Drugs for Neglected Diseases initiative (DNDi) for the treatment of human African trypanosomiasis.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: ANAC
  • CUSIP: 03242010
Key Metrics:
  • Previous Close: $99.20
  • 50 Day Moving Average: $93.23
  • 200 Day Moving Average: $81.52
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $N/A
  • Current Year EPS Consensus Estimate: $-1.58 EPS
  • Next Year EPS Consensus Estimate: $-0.61 EPS
Additional Links:
Anacor Pharmaceuticals (NASDAQ:ANAC) Chart for Sunday, July, 24, 2016